|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/352 | |
| A61K 31/375 | |||
| A61K 31/40 | |||
| A61K 31/455 | |||
| A61P 3/06 | |||
| A61P 9/10 | |||
| A23L 1/30 | |||
| A61K 36/49 |
| (11) | Number of the document | 2379072 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09811898.7 |
| Date of filing the European patent application | 2009-07-23 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/051511 |
| Date | 2009-07-23 |
| (87) | Number | WO 2010/027572 |
| Date | 2010-03-11 |
| (30) | Number | Date | Country code |
| 205070 | 2008-09-05 | US |
| (72) |
LINES, Thomas, Christian, US
|
| (73) |
Quercegen Pharmaceuticals LLC,
225 Cedar Hill Street, Suite 200, Marlborough, MA 01752,
US
|
| (54) | REDUCING CHOLESTEROL LEVELS WITH COMBINED USE OF QUERCETIN AND STATIN |
| REDUCING CHOLESTEROL LEVELS WITH COMBINED USE OF QUERCETIN AND STATIN |